Alice Ventures

novoGI™ (previously NiTi Surgical Solutions) is committed to advancing patient care by providing an expanding range of comprehensive solutions for GI disease management. NiTi Surgical Solutions has developed the first major advance in closure for gastrointestinal surgery in more than 30 years. NiTi's proprietary technology represents a breakthrough in natural healing with tissue-sparing, uniform BioDynamix anastomosis. The company's unique line of products utilizes Nitinol-based elements to press together the ends of resected tissue, enabling a natural reconnection of the intestine after removing a section, for example, as part of a colon cancer treatment. The company is commercializing a family of FDA-cleared and CE-marked disposable tissue closure devices.

Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

Tehuti Networks Ltd. operates as a fabless semiconductor company. The company provides Ethernet network traffic accelerators and Ethernet controllers. Its solutions are used in enterprise data centers, IP video servers, blade servers, and ATCA and MicroTCA platforms. The company was founded in 2003 and is based in Herzliya, Israel.

Mazor Robotics Ltd. is a medical device company specializing in the development, production, and marketing of surgical technologies for orthopedics and neurosurgery. Established in 2000 and headquartered in Caesarea, Israel, the company focuses on computer-assisted surgery, enabling high-precision and minimally invasive procedures. Its flagship products include the Mazor X and the Renaissance guidance systems, which significantly enhance the accuracy of spinal surgeries, leading to improved clinical outcomes. These systems are designed to support complex surgical procedures while providing a safer environment for patients and medical staff. With the majority of its revenue generated in the United States, Mazor Robotics continues to innovate in the field of spine surgery, raising the standard of care in surgical practices.

Andritz Powerlase Ltd. designs and manufactures high power pulsed lasers for industrial applications that include materials processing. It offers infrared, green, and ultraviolet lasers for HSTB, surface polishing, rust removal, de-painting, cleaning, laser annealing, conservation, surface structuring, and CFRP applications. Andritz Powerlase Ltd. was formerly known as Powerlase Photonics Limited and changed its name to Andritz Powerlase Ltd. in June 2017. The company was founded in 2000 and is based in Crawley, United Kingdom. Andritz Powerlase operates as a subsidiary of Andritz AG.

Intense Limited is a manufacturer and supplier of single and multimode monolithic laser array products and high-power laser diodes. The company offers a range of products, including visible and infra-red laser diode components, modules, and systems, as well as laser diode bars and individually addressable laser arrays. Intense Limited also provides foundry services such as front-end wafer processing, back-end assembly, engineering support, and product development. Additionally, the company offers design services in laser diodes, optics, electronics, and packaging. Its products cater to various sectors, including defense and security, medical, consumer and industrial applications, digital printing and imaging, and display technologies. Intense Limited, which was established in 1999 and is headquartered in Glasgow, United Kingdom, operates manufacturing facilities in both the United Kingdom and the United States, and it distributes its products through a network of distributors. The company has also formed a strategic partnership with IQE.

Ignios Ltd., an Oxford, UK-based developer of system-on-a-chip technologies.

Sagitta Ltd. is a technology-based equipment supplier for the fiber optics and semiconductor industries. A core holding of patented technologies in precision automation, machine vision and sub micron polishing has led to the introduction of multiple systems into these markets. The company has introduced the Gemini product series, a platform first in the fiber optics market to integrate the processes of polishing, cleaning and optical metrology on a single platform. Already a leader in failure analysis equipment for the semiconductor and media fields, Sagitta provides an award-winning suite of sample preparation tools used for cross sectional, SEM or TEM semiconductor inspection.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

SerCoNet is a developer of Ethernet backbone networking solutions for home consumers & SOHOs (Small Office Home Office) over existing telephone wires.

Arakis Limited is engaged in the discovery and development of medicinal products, with a focus on inflammatory diseases and oncology adjunctive therapies. The company specializes in understanding cytokine and receptor-mediated mechanisms of disease, which informs its research and development efforts. Arakis identifies and commercializes product opportunities by exploring new clinical applications for established drugs and drug templates, as well as enhancing the performance of existing medicines. Through its innovative approach, Arakis aims to address unmet medical needs in the therapeutic areas of inflammatory disease and pain.

Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.

Arakis Limited is engaged in the discovery and development of medicinal products, with a focus on inflammatory diseases and oncology adjunctive therapies. The company specializes in understanding cytokine and receptor-mediated mechanisms of disease, which informs its research and development efforts. Arakis identifies and commercializes product opportunities by exploring new clinical applications for established drugs and drug templates, as well as enhancing the performance of existing medicines. Through its innovative approach, Arakis aims to address unmet medical needs in the therapeutic areas of inflammatory disease and pain.